While Sweden’s life science industry is a good innovator, producing a huge amount of research, it needs to improve when it comes to turning knowledge into action, says Johan Järte, managing director of Swedish life science association IML, as reported by national media Biostock.
”Vinnova [Swedish innovation agency, -ed.] could for example create a financing fund. Denmark has a system with a lot of funds, which is clever because innovation is kept in the country. Sweden is a good innovator but it is often a foreign investor that ends up making money off of it instead of Sweden capitalizing on the innovation that we have financially supported through taxes,” Järte says.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Demant rejects criticisms of lobbying efforts against OTC channel: "That’s how America works"
To ensure users receive a high-quality device, CEO Søren Nielsen says Demant has lobbied the FDA through a US-based industry association as it attempts to established the rules for the upcoming over-the-counter hearing aids sales channel.
Sonova downgrades, blames high costs and weak results from key markets
The hearing aid giant now expects revenue growth of 15-19% measured in local currencies, compared to a previous 17-21%.
Demant CEO highlights strong performance from Diagnostics, acknowledges Communications letdown
The Danish hearing aid manufacturer’s diagnostics business area is a beacon of light among gloomy H1 financial figures, mostly coming from headset firm Epos, says CEO Søren Nielsen.
Analyst to hone in on Vyepti rollout and patient uptake in imminent Lundbeck report
The preventive migraine treatment, Vyepti, will likely be a key element of the Danish pharmaceutical firm’s upcoming second quarterly report on Wednesday.
US downswing reflects shift in underlying demand, says Demant CEO
Demand for hearing aids on the US market will return in the future, according to Demant CEO Søren Nielsen, who thinks people are postponing the decision to acquire a device due to the challenging economic environment.
Vice President/Senior Director of Medicinal Chemistry 
Snr. Talent Acquisition Partner, Devoteam 
Medical Scientific Communications Manager 
Senior Clinical Trial Manager - Black Swans Exist 
Global Quality Director (Business Unit Quality Lead) 
Quality coordinator for Aseptic Production, ALK 
Director Regulatory Affairs 
Senior CMC Regulatory Manage 
Key Account Manager 
GMP Compliance Consultant for Eltronic in Ballerup 
Senior Electronics Engineer 
Clinical Biometrics Oversight Lead